Albrecht Stenzinger

Research interests

Publications

• Homologous Recombination Deficiency: Concepts, Definitions, and Assays

  The Oncologist · 2022 · 10.1093/oncolo/oyab053

• Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  Annals of Oncology · 2022 · 10.1016/j.annonc.2022.10.506

• Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

  Genetics in Medicine · 2022 · 10.1016/j.gim.2022.01.001

• SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas

  Nature Metabolism · 2021 · 10.1038/s42255-021-00347-1

• Sarcoma classification by DNA methylation profiling

  Nature Communications · 2021 · 10.1038/s41467-020-20603-4

• Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers

  Cancer Discovery · 2021 · 10.1158/2159-8290.cd-21-0126

• Accurate and efficient detection of gene fusions from RNA sequencing data

  Genome Research · 2021 · 10.1101/gr.257246.119

• Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors

  Cancer Discovery · 2020 · https://doi.org/10.1158/2159-8290.cd-20-0522

• Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group

  Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.07.014

• Automated sample preparation with SP3 for low‐input clinical proteomics

  Molecular Systems Biology · 2020 · 10.15252/msb.20199111

• Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project

  Journal for ImmunoTherapy of Cancer · 2020 · https://doi.org/10.1136/jitc-2019-000147

• Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment

  Radiology · 2019 · 10.1148/radiol.2019190938

• Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisions

  Genes Chromosomes and Cancer · 2019 · 10.1002/gcc.22733

• Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy495

• Integrative genomic and transcriptomic analysis of leiomyosarcoma

  Nature Communications · 2018 · 10.1038/s41467-017-02602-0

• NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

  Cancer Discovery · 2018 · 10.1158/2159-8290.cd-18-0036

• Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and clinicians

  Translational Lung Cancer Research · 2018 · 10.21037/tlcr.2018.08.14

• CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

  Nature Medicine · 2016 · 10.1038/nm.4038

• Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells

  Nature Cell Biology · 2014 · 10.1038/ncb2994

• The landscape of metastatic progression patterns across major human cancers

  Oncotarget · 2014 · 10.18632/oncotarget.2677

• Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer

  British Journal of Cancer · 2013 · 10.1038/bjc.2013.610

• Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

  Nature Biotechnology · 2013 · https://doi.org/10.1038/nbt.2576

• BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis

  Blood · 2012 · 10.1182/blood-2012-06-429597

• Detection and Segmentation of Cell Nuclei in Virtual Microscopy Images: A Minimum-Model Approach

  Scientific Reports · 2012 · 10.1038/srep00503

• The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival

  Journal of Clinical Oncology · 2012 · 10.1200/jco.2011.37.2185

Current projects

No projects listed.